Poverty Linked With High-risk Prostate Cancer

Share this content:
Poverty is associated with an increased risk of advanced stage or aggressive prostate cancer, regardless of race.
Poverty is associated with an increased risk of advanced stage or aggressive prostate cancer, regardless of race.

SAN DIEGO—Poverty is associated with an increased risk of advanced stage or aggressive prostate cancer (PCa), regardless of race, investigators reported at the American Urological Association's 2016 annual meeting.

“Among African American men with prostate cancer, poverty appears to increase the likelihood of high-risk disease,” lead researcher Adam Reese, MD, chief of urologic oncology at Temple University School of Medicine in Philadelphia, told Renal & Urology News. “Impoverished men may be more likely to benefit from intensive prostate cancer screening and early, aggressive treatment.”

 

Dr. Reese and his colleagues studied 389 African-American PCa patients who underwent radical prostatectomy. The median household income for the cohort was $40,031 (range $14,297–$162,615). The researchers divided subjects into low- and high-income groups (below and above the median income, respectively). Adverse pathology—defined as Gleason 3+4 disease, stage pT3 or higher tumors, or lymph node involvement—was found in 40.6% of the low-income group versus 29.1% of the high-income groups, a significant difference between the groups. Significantly greater proportions of patients in the low-income group than the high-income group had seminal vesicle invasion (17.3% vs. 8.4%), positive surgical margins (35.2% vs. 22.4%), intermediate-risk cancer (38.2% vs. 23.6%), and high-risk cancer (18.8% vs. 13.0%).

RELATED: Low-Carb Diet May Curb Adverse Effects of Prostate Cancer ADT

In addition, low-income patients had higher PSA levels. For example, 17.0% and 10.1% of low-income patients had PSA levels of 10–20 and higher than 20 ng/mL, respectively, compared with 12.2% and 3.2% of high-income patients, respectively.

“Community outreach, education, and screening efforts should target low-income men to decrease prostate cancer morbidity,” the authors concluded in their study abstract.

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs

Sign Up for Free e-newsletters